US 11286279
Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions
granted A61KA61K2039/545A61K38/00
Quick answer
US patent 11286279 (Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions) held by The Regents of the University of California expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/545, A61K38/00, A61K39/0005, A61K39/0008